世界の糖尿病網膜症市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Diabetic Retinopathy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1839 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、糖尿病網膜症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（レーザー手術、コルチコステロイド注射、抗VEGF薬、硝子体切除術）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・糖尿病網膜症の市場動向 ・企業の競争状況、市場シェア ・糖尿病網膜症の種類別市場規模（レーザー手術、コルチコステロイド注射、抗VEGF薬、硝子体切除術） ・糖尿病網膜症の用途別市場規模（病院、クリニック、その他） ・糖尿病網膜症の北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病網膜症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病網膜症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病網膜症の中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病網膜症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、Roche、Novartis、TEVA、Alimera Sciences、Regeneron Pharmaceuticals、Boehringer Ingelheim、Kowa Group、Ohr Pharmaceutical、Quark Pharmaceuticals） ・結論

Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.
Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision.

Market Analysis and Insights: Global Diabetic Retinopathy Market
The global Diabetic Retinopathy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Retinopathy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Retinopathy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Retinopathy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Retinopathy market.

Global Diabetic Retinopathy Scope and Market Size
Diabetic Retinopathy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Retinopathy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Laser Surgery
Injection of Corticosteroids
Anti-VEGF Drugs
Vitrectomy

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
Roche
Novartis
TEVA
Alimera Sciences
Regeneron Pharmaceuticals
Boehringer Ingelheim
Kowa Group
Ohr Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Retinopathy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Laser Surgery
1.2.3 Injection of Corticosteroids
1.2.4 Anti-VEGF Drugs
1.2.5 Vitrectomy
1.3 Market by Application
1.3.1 Global Diabetic Retinopathy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetic Retinopathy Market Perspective (2016-2027)
2.2 Diabetic Retinopathy Growth Trends by Regions
2.2.1 Diabetic Retinopathy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Retinopathy Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Retinopathy Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Retinopathy Industry Dynamic
2.3.1 Diabetic Retinopathy Market Trends
2.3.2 Diabetic Retinopathy Market Drivers
2.3.3 Diabetic Retinopathy Market Challenges
2.3.4 Diabetic Retinopathy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetic Retinopathy Players by Revenue
3.1.1 Global Top Diabetic Retinopathy Players by Revenue (2016-2021)
3.1.2 Global Diabetic Retinopathy Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Retinopathy Revenue
3.4 Global Diabetic Retinopathy Market Concentration Ratio
3.4.1 Global Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy Revenue in 2020
3.5 Diabetic Retinopathy Key Players Head office and Area Served
3.6 Key Players Diabetic Retinopathy Product Solution and Service
3.7 Date of Enter into Diabetic Retinopathy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Retinopathy Breakdown Data by Type
4.1 Global Diabetic Retinopathy Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Retinopathy Forecasted Market Size by Type (2022-2027)

5 Diabetic Retinopathy Breakdown Data by Application
5.1 Global Diabetic Retinopathy Historic Market Size by Application (2016-2021)
5.2 Global Diabetic Retinopathy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diabetic Retinopathy Market Size (2016-2027)
6.2 North America Diabetic Retinopathy Market Size by Type
6.2.1 North America Diabetic Retinopathy Market Size by Type (2016-2021)
6.2.2 North America Diabetic Retinopathy Market Size by Type (2022-2027)
6.2.3 North America Diabetic Retinopathy Market Size by Type (2016-2027)
6.3 North America Diabetic Retinopathy Market Size by Application
6.3.1 North America Diabetic Retinopathy Market Size by Application (2016-2021)
6.3.2 North America Diabetic Retinopathy Market Size by Application (2022-2027)
6.3.3 North America Diabetic Retinopathy Market Size by Application (2016-2027)
6.4 North America Diabetic Retinopathy Market Size by Country
6.4.1 North America Diabetic Retinopathy Market Size by Country (2016-2021)
6.4.2 North America Diabetic Retinopathy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Diabetic Retinopathy Market Size (2016-2027)
7.2 Europe Diabetic Retinopathy Market Size by Type
7.2.1 Europe Diabetic Retinopathy Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Retinopathy Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Retinopathy Market Size by Type (2016-2027)
7.3 Europe Diabetic Retinopathy Market Size by Application
7.3.1 Europe Diabetic Retinopathy Market Size by Application (2016-2021)
7.3.2 Europe Diabetic Retinopathy Market Size by Application (2022-2027)
7.3.3 Europe Diabetic Retinopathy Market Size by Application (2016-2027)
7.4 Europe Diabetic Retinopathy Market Size by Country
7.4.1 Europe Diabetic Retinopathy Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Retinopathy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diabetic Retinopathy Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Retinopathy Market Size by Type
8.2.1 Asia-Pacific Diabetic Retinopathy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Retinopathy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Retinopathy Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Retinopathy Market Size by Application
8.3.1 Asia-Pacific Diabetic Retinopathy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetic Retinopathy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetic Retinopathy Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetic Retinopathy Market Size by Region
8.4.1 Asia-Pacific Diabetic Retinopathy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Retinopathy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diabetic Retinopathy Market Size (2016-2027)
9.2 Latin America Diabetic Retinopathy Market Size by Type
9.2.1 Latin America Diabetic Retinopathy Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Retinopathy Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Retinopathy Market Size by Type (2016-2027)
9.3 Latin America Diabetic Retinopathy Market Size by Application
9.3.1 Latin America Diabetic Retinopathy Market Size by Application (2016-2021)
9.3.2 Latin America Diabetic Retinopathy Market Size by Application (2022-2027)
9.3.3 Latin America Diabetic Retinopathy Market Size by Application (2016-2027)
9.4 Latin America Diabetic Retinopathy Market Size by Country
9.4.1 Latin America Diabetic Retinopathy Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Retinopathy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diabetic Retinopathy Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Retinopathy Market Size by Type
10.2.1 Middle East & Africa Diabetic Retinopathy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Retinopathy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Retinopathy Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Retinopathy Market Size by Application
10.3.1 Middle East & Africa Diabetic Retinopathy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetic Retinopathy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetic Retinopathy Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetic Retinopathy Market Size by Country
10.4.1 Middle East & Africa Diabetic Retinopathy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Retinopathy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Diabetic Retinopathy Introduction
11.1.4 Bayer Revenue in Diabetic Retinopathy Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Diabetic Retinopathy Introduction
11.2.4 Roche Revenue in Diabetic Retinopathy Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Diabetic Retinopathy Introduction
11.3.4 Novartis Revenue in Diabetic Retinopathy Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 TEVA
11.4.1 TEVA Company Details
11.4.2 TEVA Business Overview
11.4.3 TEVA Diabetic Retinopathy Introduction
11.4.4 TEVA Revenue in Diabetic Retinopathy Business (2016-2021)
11.4.5 TEVA Recent Development
11.5 Alimera Sciences
11.5.1 Alimera Sciences Company Details
11.5.2 Alimera Sciences Business Overview
11.5.3 Alimera Sciences Diabetic Retinopathy Introduction
11.5.4 Alimera Sciences Revenue in Diabetic Retinopathy Business (2016-2021)
11.5.5 Alimera Sciences Recent Development
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Diabetic Retinopathy Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2016-2021)
11.6.5 Regeneron Pharmaceuticals Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Diabetic Retinopathy Introduction
11.7.4 Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2016-2021)
11.7.5 Boehringer Ingelheim Recent Development
11.8 Kowa Group
11.8.1 Kowa Group Company Details
11.8.2 Kowa Group Business Overview
11.8.3 Kowa Group Diabetic Retinopathy Introduction
11.8.4 Kowa Group Revenue in Diabetic Retinopathy Business (2016-2021)
11.8.5 Kowa Group Recent Development
11.9 Ohr Pharmaceutical
11.9.1 Ohr Pharmaceutical Company Details
11.9.2 Ohr Pharmaceutical Business Overview
11.9.3 Ohr Pharmaceutical Diabetic Retinopathy Introduction
11.9.4 Ohr Pharmaceutical Revenue in Diabetic Retinopathy Business (2016-2021)
11.9.5 Ohr Pharmaceutical Recent Development
11.10 Quark Pharmaceuticals
11.10.1 Quark Pharmaceuticals Company Details
11.10.2 Quark Pharmaceuticals Business Overview
11.10.3 Quark Pharmaceuticals Diabetic Retinopathy Introduction
11.10.4 Quark Pharmaceuticals Revenue in Diabetic Retinopathy Business (2016-2021)
11.10.5 Quark Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diabetic Retinopathy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Laser Surgery
Table 3. Key Players of Injection of Corticosteroids
Table 4. Key Players of Anti-VEGF Drugs
Table 5. Key Players of Vitrectomy
Table 6. Global Diabetic Retinopathy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diabetic Retinopathy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Diabetic Retinopathy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Diabetic Retinopathy Market Share by Regions (2016-2021)
Table 10. Global Diabetic Retinopathy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Diabetic Retinopathy Market Share by Regions (2022-2027)
Table 12. Diabetic Retinopathy Market Trends
Table 13. Diabetic Retinopathy Market Drivers
Table 14. Diabetic Retinopathy Market Challenges
Table 15. Diabetic Retinopathy Market Restraints
Table 16. Global Diabetic Retinopathy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Diabetic Retinopathy Market Share by Players (2016-2021)
Table 18. Global Top Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Retinopathy as of 2020)
Table 19. Ranking of Global Top Diabetic Retinopathy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Diabetic Retinopathy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Diabetic Retinopathy Product Solution and Service
Table 23. Date of Enter into Diabetic Retinopathy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Diabetic Retinopathy Revenue Market Share by Type (2016-2021)
Table 27. Global Diabetic Retinopathy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Diabetic Retinopathy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Diabetic Retinopathy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Diabetic Retinopathy Revenue Market Share by Application (2016-2021)
Table 31. Global Diabetic Retinopathy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Diabetic Retinopathy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Diabetic Retinopathy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Diabetic Retinopathy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Diabetic Retinopathy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Diabetic Retinopathy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Diabetic Retinopathy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Diabetic Retinopathy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Diabetic Retinopathy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Diabetic Retinopathy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Diabetic Retinopathy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Diabetic Retinopathy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bayer Company Details
Table 64. Bayer Business Overview
Table 65. Bayer Diabetic Retinopathy Product
Table 66. Bayer Revenue in Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Diabetic Retinopathy Product
Table 71. Roche Revenue in Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Diabetic Retinopathy Product
Table 76. Novartis Revenue in Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. TEVA Company Details
Table 79. TEVA Business Overview
Table 80. TEVA Diabetic Retinopathy Product
Table 81. TEVA Revenue in Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 82. TEVA Recent Development
Table 83. Alimera Sciences Company Details
Table 84. Alimera Sciences Business Overview
Table 85. Alimera Sciences Diabetic Retinopathy Product
Table 86. Alimera Sciences Revenue in Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 87. Alimera Sciences Recent Development
Table 88. Regeneron Pharmaceuticals Company Details
Table 89. Regeneron Pharmaceuticals Business Overview
Table 90. Regeneron Pharmaceuticals Diabetic Retinopathy Product
Table 91. Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 92. Regeneron Pharmaceuticals Recent Development
Table 93. Boehringer Ingelheim Company Details
Table 94. Boehringer Ingelheim Business Overview
Table 95. Boehringer Ingelheim Diabetic Retinopathy Product
Table 96. Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 97. Boehringer Ingelheim Recent Development
Table 98. Kowa Group Company Details
Table 99. Kowa Group Business Overview
Table 100. Kowa Group Revenue in Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 101. Kowa Group Recent Development
Table 102. Ohr Pharmaceutical Company Details
Table 103. Ohr Pharmaceutical Business Overview
Table 104. Ohr Pharmaceutical Diabetic Retinopathy Product
Table 105. Ohr Pharmaceutical Revenue in Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 106. Ohr Pharmaceutical Recent Development
Table 107. Quark Pharmaceuticals Company Details
Table 108. Quark Pharmaceuticals Business Overview
Table 109. Quark Pharmaceuticals Diabetic Retinopathy Product
Table 110. Quark Pharmaceuticals Revenue in Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 111. Quark Pharmaceuticals Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Retinopathy Market Share by Type: 2020 VS 2027
Figure 2. Laser Surgery Features
Figure 3. Injection of Corticosteroids Features
Figure 4. Anti-VEGF Drugs Features
Figure 5. Vitrectomy Features
Figure 6. Global Diabetic Retinopathy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Diabetic Retinopathy Report Years Considered
Figure 11. Global Diabetic Retinopathy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Diabetic Retinopathy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Diabetic Retinopathy Market Share by Regions: 2020 VS 2027
Figure 14. Global Diabetic Retinopathy Market Share by Regions (2022-2027)
Figure 15. Global Diabetic Retinopathy Market Share by Players in 2020
Figure 16. Global Top Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Retinopathy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Diabetic Retinopathy Revenue in 2020
Figure 18. Global Diabetic Retinopathy Revenue Market Share by Type (2016-2021)
Figure 19. Global Diabetic Retinopathy Revenue Market Share by Type (2022-2027)
Figure 20. North America Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Diabetic Retinopathy Market Share by Type (2016-2027)
Figure 22. North America Diabetic Retinopathy Market Share by Application (2016-2027)
Figure 23. North America Diabetic Retinopathy Market Share by Country (2016-2027)
Figure 24. United States Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Diabetic Retinopathy Market Share by Type (2016-2027)
Figure 28. Europe Diabetic Retinopathy Market Share by Application (2016-2027)
Figure 29. Europe Diabetic Retinopathy Market Share by Country (2016-2027)
Figure 30. Germany Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Diabetic Retinopathy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Diabetic Retinopathy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Diabetic Retinopathy Market Share by Region (2016-2027)
Figure 40. China Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Diabetic Retinopathy Market Share by Type (2016-2027)
Figure 48. Latin America Diabetic Retinopathy Market Share by Application (2016-2027)
Figure 49. Latin America Diabetic Retinopathy Market Share by Country (2016-2027)
Figure 50. Mexico Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Diabetic Retinopathy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Diabetic Retinopathy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Diabetic Retinopathy Market Share by Country (2016-2027)
Figure 56. Turkey Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bayer Revenue Growth Rate in Diabetic Retinopathy Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Diabetic Retinopathy Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Diabetic Retinopathy Business (2016-2021)
Figure 62. TEVA Revenue Growth Rate in Diabetic Retinopathy Business (2016-2021)
Figure 63. Alimera Sciences Revenue Growth Rate in Diabetic Retinopathy Business (2016-2021)
Figure 64. Regeneron Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2016-2021)
Figure 65. Boehringer Ingelheim Revenue Growth Rate in Diabetic Retinopathy Business (2016-2021)
Figure 66. Kowa Group Revenue Growth Rate in Diabetic Retinopathy Business (2016-2021)
Figure 67. Ohr Pharmaceutical Revenue Growth Rate in Diabetic Retinopathy Business (2016-2021)
Figure 68. Quark Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---